- Home
- MDAI vs INKT Comparison
MDAI vs INKT Comparison
Compare MDAI & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- INKT
- Stock Information
- Founded
- MDAI 2013
- INKT 2017
- Country
- MDAI United States
- INKT United States
- Employees
- MDAI N/A
- INKT N/A
- Industry
- MDAI Medical/Dental Instruments
- INKT Medicinal Chemicals and Botanical Products
- Sector
- MDAI Health Care
- INKT Health Care
- Exchange
- MDAI Nasdaq
- INKT Nasdaq
- Market Cap
- MDAI 23.8M
- INKT 28.5M
- IPO Year
- MDAI N/A
- INKT 2021
- Fundamental
- Price
- MDAI $1.14
- INKT $0.69
- Analyst Decision
- MDAI Strong Buy
- INKT Strong Buy
- Analyst Count
- MDAI 3
- INKT 2
- Target Price
- MDAI $4.50
- INKT $6.50
- AVG Volume (30 Days)
- MDAI 587.1K
- INKT 34.8K
- Earning Date
- MDAI 11-06-2024
- INKT 11-14-2024
- Dividend Yield
- MDAI N/A
- INKT N/A
- EPS Growth
- MDAI N/A
- INKT N/A
- EPS
- MDAI N/A
- INKT N/A
- Revenue
- MDAI $27,264,000.00
- INKT N/A
- Revenue This Year
- MDAI $59.53
- INKT N/A
- Revenue Next Year
- MDAI N/A
- INKT N/A
- P/E Ratio
- MDAI N/A
- INKT N/A
- Revenue Growth
- MDAI 44.52
- INKT N/A
- 52 Week Low
- MDAI $0.82
- INKT $0.57
- 52 Week High
- MDAI $3.72
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- MDAI 40.97
- INKT 41.84
- Support Level
- MDAI $1.35
- INKT $0.67
- Resistance Level
- MDAI $1.58
- INKT $0.75
- Average True Range (ATR)
- MDAI 0.18
- INKT 0.05
- MACD
- MDAI -0.04
- INKT -0.01
- Stochastic Oscillator
- MDAI 22.03
- INKT 17.99
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.